Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.

@article{Bhavsar2012NeutrophilGL,
  title={Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.},
  author={N. Bhavsar and A. K{\"o}ttgen and J. Coresh and B. Astor},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={2012},
  volume={60 2},
  pages={
          233-40
        }
}
  • N. Bhavsar, A. Köttgen, +1 author B. Astor
  • Published 2012
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
BACKGROUND Identifying individuals at risk of chronic kidney disease (CKD) is critical for timely treatment initiation to slow progression of the disease. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) are known biomarkers of acute kidney injury, but it is unknown whether these markers are associated with incident CKD stage 3 in the general population. STUDY DESIGN Matched case-control study. SETTING & PARTICIPANTS African American and white… Expand
Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
  • Edward R. Smith, Darren Lee, +4 authors S. Holt
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2013
Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
  • K. Liu, W. Yang, +13 authors Chi-Yuan Hsu
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2015
Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients
Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy
Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.
Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 49 REFERENCES
Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
...
1
2
3
4
5
...